Prevalence Of Oral Mucosal Alterations In Diabetes Mellitus Type2

Sponsor
Alaa Mahmoud abd El kader (Other)
Overall Status
Completed
CT.gov ID
NCT03670797
Collaborator
Cairo University (Other)
500
1
7.8
63.9

Study Details

Study Description

Brief Summary

There are severe deficiency of database concerning the oral health status in Egyptian patients with Diabetes type 2. Our aim in the present study is to study the prevalence of oral mucosal alterations in type 2 DM patients and the effect of hyperglycemia on these alterations in controlled and uncontrolled patients to increase their awareness and minimize all the possible risk factors,to achieve a proper management for all oral problems.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The study will be held in the Endocrine clinic at El Kasr Al-Ainy Cairo University Hospital for patients with diabetes mellitus type2. The data collected through the questionnaire will be obtained through an interview between the investigator and the patient.Clinical examination will be performed for the oral cavity.Blood sample will be withdrawn from each participant and collected in the clinical pathology lab in El kasr Al Ainy to measure the glycosylated hemoglobin concentration.The salivary gland function will be determined through a small questionnaire and clinical examination of the patient.

    Selection bias: will be minimized by enrolling the participants in the study in a consecutive order of the entering the clinic.

    Non-respondent bias: will be minimized by explaining to the participants the aim of the study and their importance and role in the study.

    Incomplete records: will be excluded from statistical analysis with reporting the cause of not completing the record.

    Sample size estimation:

    Based on the previous papers by AL-Maweri,et al ,2013, the prevalence of oral mucosal alterations in diabetic patients 45.1%.Using a precision of 5, a design effect set at 1 with 95% CI (confidence interval), a total sample size of 381 will be sufficient. The sample size was calculated by Epi info.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    500 participants
    Observational Model:
    Ecologic or Community
    Time Perspective:
    Cross-Sectional
    Official Title:
    Prevalence Of Oral Mucosal Alterations In a Sample of Egyptian Patients With Diabetes Mellitus Type2: A Hospital Based Cross Sectional Study
    Actual Study Start Date :
    Dec 25, 2018
    Actual Primary Completion Date :
    Jul 30, 2019
    Actual Study Completion Date :
    Aug 20, 2019

    Arms and Interventions

    Arm Intervention/Treatment
    controlled diabetic patients

    uncontrolled diabetic patients

    Outcome Measures

    Primary Outcome Measures

    1. Oral mucosal alterations [10 min]

      Clinical examination according to WHO guidelines by Dichotomous outcome (Yes/No).

    Secondary Outcome Measures

    1. Periodontal condition [10 min]

      Basic periodontal examination by Continuous outcome (Score codes).

    2. Salivary glands function [10 min]

      Clinical oral dryness examination and Self estimated questionnaire by Dichotomous outcome (Yes/No).

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    25 Years to 90 Years
    Sexes Eligible for Study:
    All
    Inclusion Criteria:
    1. Adult patients

    2. Patients >25years old

    3. Patients diagnosed with diabetes type 2.

    4. Egyptian patients.

    Exclusion Criteria:
    1. females diagnosed with gestational diabetes.

    2. Patients not physically able to participate in survey or clinical oral examination.

    3. Patients with other systemic diseases which may cause oral manifestation as liver disorders.

    4. Patients under immunosuppressive drugs.

    5. Patients under corticosteriods.

    6. Patients with organ transplantation.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Alaa Mahmoud Abd El Kader Cairo Egypt 2020

    Sponsors and Collaborators

    • Alaa Mahmoud abd El kader
    • Cairo University

    Investigators

    • Study Chair: Mariam fakhr, the Endocrine units at the Kasr Al-Ainy Cairo university hospital.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Alaa Mahmoud abd El kader, principle investigator, internal resident at oral medicine department, Cairo University
    ClinicalTrials.gov Identifier:
    NCT03670797
    Other Study ID Numbers:
    • Diabetes-Oral Alterations
    First Posted:
    Sep 14, 2018
    Last Update Posted:
    Jan 28, 2020
    Last Verified:
    Jan 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Alaa Mahmoud abd El kader, principle investigator, internal resident at oral medicine department, Cairo University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 28, 2020